Search - tctmd.com

Displaying 81 - 100 of 220

Sort: Relevancy | Date

Presentation TCT 2023

TCT 846: First-in-Human Treatment of Severe Tricuspid Regurgitation using a novel Cross-Caval Heterotopic Device

Presenter: Rodrigo Estevez-Loureiro

October 26, 2023

Presentation TCT 2023

TCT 845: BICAVAL VALVE IMPLANTATION FOR SEVERE TRICUSPID REGURGITATION IN A NONAGENARIAN PATIENT - ONE YEAR FOLLOW UP

Presenter: Edgar Lamas

October 26, 2023

Presentation TCT 2023

TCT 844: Torrential tricuspid regurgitation due to carcinoid syndrome percutaneously treated, prosthesis migration resolved

Presenter: Manuel Duarte

October 26, 2023

Presentation TCT 2023

Natural History and New Classification of Tricuspid Regurgitation

Presenter: Anna Sannino

October 25, 2023

Presentation TCT 2023

A Novel Heterotopic Tricuspid Regurgitation Device for the Treatment of Tricuspid Regurgitation (Innoventric)

Presenter: Philipp Lurz

October 25, 2023

Presentation TCT 2023

The CROIVALVE Duo System for the Percutaneous Treatment of Tricuspid Regurgitation: Technology and Program Update

Presenter: Adam Witkowski

October 25, 2023

Presentation TCT 2023

Safety and Efficacy of a Novel Vertical Spacer with Atraumatic Anchoring for Tricuspid Regurgitation: A First-in-Man Experience (Pivot Bridge)

Presenter: Joo-Yong Hahn

October 25, 2023

Presentation TCT 2023

Validation of the Kansas City Cardiomyopathy Questionnaire in Patients With Tricuspid Regurgitation: The Tri-QOL Study

Presenter: Suzanne Arnold

October 25, 2023

Presentation TCT 2023

TCT 295: Race and Ethnicity in Patients With Severe Tricuspid Regurgitation: An Exploration of Disparities

Presenter: Julio Echarte- Morales

October 25, 2023

Presentation TCT 2023

TCT 173: Gender Differences of Tricuspid Regurgitation Progression in Patients After Left-sided Valve Intervention

Presenter: Cheng Wang

October 25, 2023

Presentation TCT 2023

TCT 350: Statistics of In-patient Mortality and Associated Variables of Transcatheter Mitral Valve-in-Valve (TMVR ViV) Procedure in Mitral Stenosis and Mitral Regurgitation with Bioprosthetic Valve- A Nationwide Analysis

Presenter: Aneeza Jamshed

October 25, 2023

Presentation TCT 2023

TCT 260: Tricuspid Regurgitation and Heart Failure: the Fate of Treated vs Untreated in the Percutaneous Era. What is clear now?

Presenter: edoardo zancanaro

October 25, 2023

Presentation TCT 2023

TCT 481: Improvement of Tricuspid Regurgitation by Interventional Annuloplasty - One-Year Outcomes of a Single-Center Registry

Presenter: Stephan Haussig

October 25, 2023

Presentation TCT 2023

TCT 72: Improvement in Echocardiographic Mitral Regurgitation Parameters Correlates With LV Reverse Remodelling in Patients Undergoing Percutaneous Mitral Annuloplasty With the Carillon Technique

Presenter: Tomasz Siminiak

October 25, 2023

Presentation TCT 2023

TCT 70: Comparison of the Outcomes of Mitral Annuloplasty With the Carillon Device in Patients With Proportionate and Disproportionate Functional Mitral Regurgitation

Presenter: Tomasz Siminiak

October 25, 2023

News Conference News TCT 2023

More TRILUMINATE Patients Flesh Out Tricuspid TEER’s Impact

Yael L. Maxwell

October 24, 2023

Presentation TCT 2023

Case: Mitral Regurgitation and Tricuspid Regurgitation

Presenter: Laura Davidson

October 24, 2023

Presentation TCT 2023

TRILUMINATE Pivotal: Outcomes of Both Randomized and Single-arm Subjects with Transcatheter Tricuspid Valve Edge-to-Edge Repair for Tricuspid Regurgitation

Presenter: David Adams

October 24, 2023

News Conference News TCT 2022

Mix of Patient, Procedural, and Device Factors All Drove TAVI Advances

Caitlin E. Cox

September 19, 2022

News Conference News TCT 2022

Pulmonary Artery Denervation in Idiopathic PAH Ups 6-Minute Walk Test

Shelley Wood

September 18, 2022

Advertisement

TCT 846: First-in-Human Treatment of Severe Tricuspid Regurgitation using a novel Cross-Caval Heterotopic Device

TCT 845: BICAVAL VALVE IMPLANTATION FOR SEVERE TRICUSPID REGURGITATION IN A NONAGENARIAN PATIENT - ONE YEAR FOLLOW UP

TCT 844: Torrential tricuspid regurgitation due to carcinoid syndrome percutaneously treated, prosthesis migration resolved

Natural History and New Classification of Tricuspid Regurgitation

A Novel Heterotopic Tricuspid Regurgitation Device for the Treatment of Tricuspid Regurgitation (Innoventric)

The CROIVALVE Duo System for the Percutaneous Treatment of Tricuspid Regurgitation: Technology and Program Update

Safety and Efficacy of a Novel Vertical Spacer with Atraumatic Anchoring for Tricuspid Regurgitation: A First-in-Man Experience (Pivot Bridge)

Validation of the Kansas City Cardiomyopathy Questionnaire in Patients With Tricuspid Regurgitation: The Tri-QOL Study

TCT 295: Race and Ethnicity in Patients With Severe Tricuspid Regurgitation: An Exploration of Disparities

TCT 173: Gender Differences of Tricuspid Regurgitation Progression in Patients After Left-sided Valve Intervention

TCT 350: Statistics of In-patient Mortality and Associated Variables of Transcatheter Mitral Valve-in-Valve (TMVR ViV) Procedure in Mitral Stenosis and Mitral Regurgitation with Bioprosthetic Valve- A Nationwide Analysis

TCT 260: Tricuspid Regurgitation and Heart Failure: the Fate of Treated vs Untreated in the Percutaneous Era. What is clear now?

TCT 481: Improvement of Tricuspid Regurgitation by Interventional Annuloplasty - One-Year Outcomes of a Single-Center Registry

TCT 72: Improvement in Echocardiographic Mitral Regurgitation Parameters Correlates With LV Reverse Remodelling in Patients Undergoing Percutaneous Mitral Annuloplasty With the Carillon Technique

TCT 70: Comparison of the Outcomes of Mitral Annuloplasty With the Carillon Device in Patients With Proportionate and Disproportionate Functional Mitral Regurgitation

More TRILUMINATE Patients Flesh Out Tricuspid TEER’s Impact

Case: Mitral Regurgitation and Tricuspid Regurgitation

TRILUMINATE Pivotal: Outcomes of Both Randomized and Single-arm Subjects with Transcatheter Tricuspid Valve Edge-to-Edge Repair for Tricuspid Regurgitation

Mix of Patient, Procedural, and Device Factors All Drove TAVI Advances

Pulmonary Artery Denervation in Idiopathic PAH Ups 6-Minute Walk Test

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content